Exercise-induced Bronchoconstriction
📧 Sign up to get email alerts when something new happens for Exercise-induced Bronchoconstriction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Hypoxic Environment on EIB and Performance in Race Walkers
A completed clinical trial evaluated how a hypoxic environment affects exercise-induced bronchoconstriction and performance in race walkers.
-
FDA approval · 2025-09-30FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for Montelukast Sodium by Amneal Pharmaceuticals LLC. This approval relates to an updated labeling o…
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: A Study to Investigate the Effects of PT027 (Budesonide/Albuterol Sulfate) Metered-dose Inhaler Compared With Placebo on Exercise-Induced Bronchoconstriction in Adult Patients With Asthma [Phase 3]
A Phase 3 trial evaluating PT027 (budesonide/albuterol sulfate) inhaler vs placebo in adults with asthma and exercise-induced bronchoconstri…
-
CLINICAL_TRIALS trial_result · 2025-08-26Clinical Trial Update: Exercise Induced Bronchoconstriction and Field Tests [NA]
Karolinska Institutet's trial evaluating exercise-induced bronchoconstriction and field tests has completed.
-
FDA approval · 2025-07-01FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved a supplemental application for montelukast sodium from Ajanta Pharma USA Inc., updating the approved ANDA product via a supplem…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-07-01FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Ajanta Pharma USA Inc.)
The FDA approved a supplemental application for Montelukast Sodium from Ajanta Pharma USA Inc., under an ANDA.
-
FDA approval · 2025-07-01FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved a supplemental application for Montelukast Sodium (generic montelukast) submitted by Ajanta Pharma USA Inc. under ANDA203328.
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: Inspiratory Muscle Training on The Severity of Exercise-Induced Bronchoconstriction and Time-Trial Performance (IMT_EIB) [NA]
A clinical trial update indicates the Inspiratory Muscle Training for Exercise-Induced Bronchoconstriction (IMT_EIB) study has completed.
-
FDA approval · 2025-04-16FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for Montelukast sodium (generic montelukast) submitted by Amneal Pharmaceuticals LLC under ANDA20510…
-
FDA approval · 2025-04-03FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited's supplemental application for montelukast sodium (ANDA 201515), enabling the approval of a gen…
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: Salbutamol Use in Ozone Air Pollution by People With Asthma and/or Exercise Induced Bronchoconstriction (EIB) [Phase 4]
Phase 4 trial assessing salbutamol use in people with asthma or exercise-induced bronchoconstriction exposed to ozone air pollution; results…
-
FDA approval · 2024-09-27FDA Approved: MONTELUKAST — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for Montelukast from BluePoint Laboratories under an ANDA, resulting in regulatory approval of t…
-
CLINICAL_TRIALS research · 2024-06-28Clinical Trial Update: Prevalence of EILO Among Children With Asthma [NA]
A clinical trial update describes a study to determine how prevalent exercise-induced laryngeal obstruction is among children with asthma; t…
-
FDA approval · 2024-05-21FDA Approved: ALBUTEROL SULFATE — Original Application (Armstrong Pharmaceuticals, Inc.)
FDA approved the original generic application for albuterol sulfate from Armstrong Pharmaceuticals, Inc. as a generic bronchodilator. It is …
-
FDA approval · 2024-05-17FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for Montelukast Sodium from Rising Pharma Holdings, Inc., authorizing its generic montelukast pr…
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: Exercise Induced Bronchoconstriction (0476-359) [Phase 1]
Phase 1 trial update for a program addressing exercise-induced bronchoconstriction in asthma; the Organon-sponsored study (identifier 0476-3…
-
FDA approval · 2023-11-27FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Dr.Reddy's Laboratories Limited)
The FDA approved a supplemental application for montelukast sodium from Dr. Reddy's Laboratories Limited, representing an additional approva…
-
FDA approval · 2023-11-27FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for Montelukast Sodium from Dr. Reddy's Laboratories Limited under an ANDA, enabling a supplemental …
-
FDA approval · 2023-11-21FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Accord Healthcare Inc.)
FDA approves Accord Healthcare Inc.'s Montelukast Sodium supplemental application for the generic product, enabling its labeling and market …
-
FDA approval · 2023-10-02FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Westminster Pharmaceuticals, LLC)
The FDA approved Westminster Pharmaceuticals, LLC's supplemental application for Montelukast Sodium, a generic product under an ANDA.
-
FDA approval · 2023-09-21FDA Approved: MONTELUKAST — Supplemental Application (XLCare Pharmaceuticals Inc.)
The FDA approved a supplemental application for Montelukast from XLCare Pharmaceuticals Inc., authorizing a supplemental action related to a…
-
CLINICAL_TRIALS trial_result · 2023-08-03Clinical Trial Update: Influence of Cromones on Eucapnic Hyperventilation (EVH)-Test in Young (Elite) Athletes Who Tested Positive for EIB. [Phase 3]
Phase 3 trial evaluating the influence of cromones on the EVH test in elite young athletes with exercise-induced bronchoconstriction; the st…
-
FDA approval · 2023-07-31FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for Montelukast Sodium from Macleods Pharmaceuticals Limited, authorizing continued marketing of thi…
-
FDA approval · 2023-06-28FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental ANDA for Montelukast Sodium from Unichem Pharmaceuticals (USA), Inc., adding a generic Montelukast Sodium produc…
-
FDA approval · 2023-06-26FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Lannett Company, Inc.)
FDA approves a supplemental application for montelukast sodium from Lannett Company, Inc., under ANDA200405, authorizing an updated generic …